Cervical cancer is a type of cancer that originates in the cervix—the lower part of the uterus that connects to the vagina.

The global vaginal specula market is on a steady growth trajectory, with the market size estimated at USD 936.0 million in 2023 and projected to grow to USD 1,301.5 million by 2033, expanding at a ...

A safe alternative to clinician-administered tests, the self-test for HPV can help prevent cervical cancer. Read more at ...

A DRUG prescribed to 300,000 women has been dubbed ‘the hidden thalidomide’ as it’s feared to have triggered rare cancers.

The family of a mother who died from cervical cancer after twice being wrongly told she had negative results have been ...

The U.S. Food and Drug Administration has approved Jobevne (bevacizumab-nwgd), a biosimilar to Avastin (bevacizumab) for ...

BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative ...

Supporting health authorities’ efforts to achieve national health indicators related to cervical cancer prevention and ...

Four leading companies CTMC, Iovance Therapeutics, KSQ, and TILT Biotherapeutics prognosticate coming successes of new technology approaches to better tumor-infiltrating lymphocyte activities.

M-Strip, the self-sampling kit for cervical cancer (HPV) and STI screening, provides a non-invasive alternative to ...

Researchers at AIIMS, Delhi have developed a simple blood test using droplet digital PCR (ddPCR) to track the effectiveness of cervical cancer treatment. Published in Scientific Reports, the study ...

In Côte d'Ivoire, nearly 90% of cervical cancer screenings are conducted through self-testing, empowering women to take charge of their health. This approach allows for detection in a private, ...